Exercise of Options
25/02/2021Appendix 4D and Interim Financial Report
16/02/2021Response to Price Query
08/02/2021Proteomics International seeks FDA approval for PromarkerD
28/01/2021Update – Proposed issue of Securities – PIQ
28/01/2021Issue of Options and Secondary Trading Notice
28/01/2021Results of Meeting
28/01/2021Appendix 4C – December 2021 Quarterly Update